pramipexole dihydrochloride 1 MG pramipexole 0.7 MG Oral Tablet
1 INDICATIONS AND USAGE Pramipexole dihydrochloride is a non-ergot dopamine agonist indicated for the treatment of: Parkinsonβs disease (PD) (1.1) Moderate-to-severe primary Restless Legs Syndrome (RLS) ( 1.2 ) 1.1 Parkinson's Disease Pramipexole dihydrochloride tablets are indicated for the treatment of Parkinson's disease. 1.2 Restless Legs Syndrome Pramipexole dihydrochloride tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
aurobindo pharma limited
ROUND WHITE Y 45
Y 45 ROUND WHITE
Related Pills
pramipexole 1.5 mg
aurobindo pharma limited
pramipexole 0.5 mg
aurobindo pharma limited
Pramipexole dihydrochloride 0.25 MG Oral Tablet
aurobindo pharma limited
Trientine hydrochloride 250 MG Oral Capsule
Dr.Reddys Laboratories Inc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
PRAMIPEXOLE DIHYDROCHLORIDE tablets are available as follows:
PRAMIPEXOLE DIHYDROCHLORIDE Tablets, 0.125 mg are white to off-white, round, flat, beveled edge uncoated tablets, debossed with βYβ on one side β41β on other side. Bottles of 90 NDC 65862-604-90 Bottles of 1,000 NDC 65862-604-99 Cartons of 100 (10 x 10) Unit-dose Tablets NDC 65862-604-78
PRAMIPEXOLE DIHYDROCHLORIDE Tablets, 0.25 mg are white to off-white, oval, biconcave, beveled edge uncoated tablets, debossed with βYβ and β42β separated by score line on one side and plain with score line on other side. Bottles of 90 NDC 65862-605-90 Bottles of 1,000 NDC 65862-605-99 Cartons of 100 (10 x 10) Unit-dose Tablets NDC 65862-605-78
PRAMIPEXOLE DIHYDROCHLORIDE Tablets, 0.5 mg are white to off-white, oval, biconcave, beveled edge uncoated tablets, debossed with βYβ and β43β separated by score line on one side and plain with score line on other side. Bottles of 90 NDC 65862-606-90 Bottles of 1,000 NDC 65862-606-99 Cartons of 100 (10 x 10) Unit-dose Tablets NDC 65862-606-78
PRAMIPEXOLE DIHYDROCHLORIDE Tablets, 0.75 mg are white to off-white, oval, biconcave, beveled edge uncoated tablets, debossed with βYβ on one side and β44β on other side. Bottles of 90 NDC 65862-607-90 Bottles of 1,000 NDC 65862-607-99 Cartons of 100 (10 x 10) Unit-dose Tablets NDC 65862-607-78
PRAMIPEXOLE DIHYDROCHLORIDE Tablets, 1 mg are white to off-white, round, flat, beveled edge uncoated tablets, debossed with βYβ and β45β separated by score line on one side and plain with score line on other side. Bottles of 90 NDC 65862-608-90 Bottles of 1,000 NDC 65862-608-99 Cartons of 100 (10 x 10) Unit-dose Tablets NDC 65862-608-78
PRAMIPEXOLE DIHYDROCHLORIDE Tablets, 1.5 mg are white to off-white, round, flat, beveled edge uncoated tablets, debossed with βYβ and β46β separated by score line on one side and plain with score line on other side. Bottles of 90 NDC 65862-609-90 Bottles of 1,000 NDC 65862-609-99 Cartons of 100 (10 x 10) Unit-dose Tablets NDC 65862-609-78 16.2 Storage and Handling Store at 20Β° to 25Β°C (68Β° to 77Β°F) [see USP Controlled Room Temperature]. Protect from light. Store in a safe place out of the reach of children.
More pills like ROUND Y 45